reata pharmaceuticals stock price

The high in the last 52 weeks of Reata Pharmaceuticals stock was 11480. RETA stock opened at 3466 on Wednesday.

Reata Pharmaceuticals Can Rally Nasdaq Reta Seeking Alpha

View Reata Pharmaceuticals Inc RETA investment stock information.

. RETA Reata the Company our us or we a clinical-stage biopharmaceutical company today. These stocks are the best BUYS for. Presently Reata Pharmaceuticals Inc.

Baird Lowers Reata Pharmaceuticals Price Target to 27 From 37 Maintains Market Neutral Rating. Shares are logging -7387 during the 52-week period from high price and 6243 higher than the lowest price point for the same. Oct 28 40159 PM GMT-4 USD NASDAQ Disclaimer.

Sep 2017 2018 2019 2020 2021 2022 10 20 30 40 50 0 2M 4M 6M 8M. Reata Pharmaceuticals Inc. The share prices change because of supply and demand.

Shares of Reata Pharmaceuticals Inc. View the latest Reata Pharmaceuticals Inc. 102 rows Discover historical prices for RETA stock on Yahoo Finance.

PLANO Texas October 31 2022--Reata Pharmaceuticals Inc. According to the current price Reata Pharmaceuticals is 2909 away from the 52-week high. Stock Advisor list price is 199 per year.

Reata Pharmaceuticals has a 52-week low of 1847 and a 52-week high of 11480. Clinical-stage biopharmaceutical companies Karuna Therapeutics KRTX 143 and Reata Pharmaceuticals RETA-060. Get the latest Reata Pharmaceuticals Inc RETA detailed stock quotes stock data Real-Time ECN.

Reata Pharmaceuticals Announces Three Month Extension. Shares of RETA stock opened at 3000 on Friday. NASDAQRETA Get Rating have been assigned a consensus rating of Hold from the nine ratings firms that are currently covering.

Get Reata Pharmaceuticals Inc RETANASDAQ real-time stock quotes news price and financial information from CNBC. Reata Pharmaceuticals Inc - Ordinary Shares - Class A 3000 266. Class A Common Stock RETA Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets.

RETA Reata Pharmaceuticals Inc - Ordinary Shares - Class A Stock Price and Discussion Stocktwits. RETA Reata the Company our us or we a clinical-stage biopharmaceutical company today announced that it will report financial. Cl A RETA stock price news historical charts analyst ratings and financial information from WSJ.

Reata Pharmaceuticals has a 52 week low of 1847 and a 52 week high of 11480. A-RATED STOCKS are those stocks the Big Data multi-factor models score as most probable to rise in price. View daily weekly or monthly format.

The companys Stock price change every day as a result of market forces. The firm has a 50-day simple moving average of. The stock has a market cap of 109.

2 hours agoReata Pharmaceuticals Inc.

Reata Pharmaceuticals Inc Reta Stock Price Quote News Stock Analysis